Castleark Management LLC Axonics, Inc. Transaction History

Castleark Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $5.59 Million - $7.22 Million	113,200 New	113,200 $7.04 Million
Q4 2022 Feb 09, 2023	BUY	$59.56 - $76.6 $116,142 - $149,370	1,950 Added 1.59%	124,520 $7.79 Million
Q3 2022 Nov 15, 2022	BUY	$57.96 - $78.12 $1.42 Million - $1.92 Million	24,520 Added 25.01%	122,570 $8.63 Million
Q2 2022 Aug 16, 2022	BUY	$39.5 - $64.42 $517,134 - $843,386	13,092 Added 15.41%	98,050 $5.56 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $1.2 Million - $1.72 Million	27,420 Added 47.66%	84,958 $5.32 Million
Q4 2021 Feb 16, 2022	SELL	$50.01 - $73.35 $4.84 Million - $7.09 Million	-96,685 Reduced 62.69%	57,538 $3.22 Million
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $2.47 Million - $3.28 Million	41,641 Added 36.99%	154,223 $10 Million
Q2 2021 Aug 17, 2021	BUY	$51.39 - $66.9 $1.32 Million - $1.72 Million	25,665 Added 29.53%	112,582 $7.14 Million
Q1 2021 May 14, 2021	SELL	$49.14 - $59.89 $7.06 Million - $8.6 Million	-143,680 Reduced 62.31%	86,917 $5.21 Million
Q4 2020 Feb 17, 2021	SELL	$42.19 - $51.5 $1.85 Million - $2.26 Million	-43,967 Reduced 16.01%	230,597 $11.5 Million
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $1.83 Million - $2.64 Million	51,742 Added 23.22%	274,564 $14 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $4.11 Million - $7.14 Million	179,194 Added 410.73%	222,822 $7.82 Million
Q1 2020 May 13, 2020	BUY	$16.44 - $37.73 $717,244 - $1.65 Million	43,628 New	43,628 $1.11 Million

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.